Medical News

RSS

NOXXON to commence multiple ascending dose study of MCP-1 targeting anti-inflammatory Spiegelmer NOX-E36

NOXXON Pharma AG announced today that it has permission to commence a multiple ascending dose study of its Monocyte Chemoattractant Protein-1 (MCP-1) targeting anti-inflammatory Spiegelmer®, NOX-E36. NOXXON plans to develop NOX-E36 for the treatment of diabetic nephropathy and other diabetes related complications.

7 Jul 2010

Wichita Clinic plans to implement Centricity EMR solutions from GE Healthcare

With more than 160 doctors covering 40 specialty care areas, Kansas' largest physician-owned practice is the latest to choose GE Centricity solutions to help drive patient care enhancements and cost reductions.

7 Jul 2010

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

International Stem Cell Corporation and Sankara Nethralaya, announced today commencement of a collaboration to develop ISCO's "CytoCor™" stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. "This is one more step in ISCO's stated plan of building its portfolio of therapeutic agents through strategic alliances throughout the world," said Chairman, Ken Aldrich.

7 Jul 2010

Testimony on importance of addressing health literacy in healthcare communications released

Health Dialog today released testimony on the importance of addressing health literacy in healthcare communications. The testimony was presented before the ERISA Advisory Council during a hearing on July 1, 2010. The council advises the U.S. Secretary of Labor on a number of employee benefits-related issues.

7 Jul 2010

Uptake Medical completes Series B financing led by Maverick Capital

Uptake Medical, a privately held interventional pulmonology company, announced today that it has concluded its Series B financing from an investment group led by Maverick Capital, a new investor. The company plans to use this capital to obtain the CE mark and introduce its unique proprietary Bronchoscopic Thermal Vapor Ablation (BTVA) technology outside of the U.S. The company also has begun its approval cycle with the FDA in the U.S.

7 Jul 2010

Winston submits NDA for CIVANEX to U.S. FDA

Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for approval to market its civamide (zucapsaicin) 0.075% cream, CIVANEX®, for the treatment of signs and symptoms of osteoarthritis of the knee.

7 Jul 2010

FDA grants orphan drug designation for Synageva BioPharma's SBC-102

Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.

7 Jul 2010

Neoprobe initiates third multi-center Phase 3 clinical study of Lymphoseek

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that a third multi-center Phase 3 clinical study of Lymphoseek (NEO3-09) has received investigational review board approval and begun enrollment of subjects diagnosed with breast cancer or melanoma.

7 Jul 2010

Opsens third-quarter revenues increase 15% to $1,469,000

Opsens Inc. today released its financial results for the three- and nine-month periods ended May 31, 2010.

7 Jul 2010

Biomerics enters into strategic partnership with Diamond Mold

Biomerics, a leader and innovator of medical polymer solutions, announced today that it has entered into a strategic partnership with Diamond Mold, of Salt Lake City, Utah.

7 Jul 2010

Skilled Healthcare Group to challenge Humboldt County verdict

Skilled Healthcare Group, Inc. today reported that a jury in Humboldt County, California, returned a verdict against the Company related to a complaint filed more than four years ago. The case has been disclosed in the Company's prior Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K.

7 Jul 2010

Method of suicide attempt predicts subsequent successful suicide: Study

The method used for a suicide attempt is highly significant for the risk of subsequent successful suicide, reveals a long-term study from Karolinska Institutet. The results may be of help in acute risk assessment following a suicide attempt.

7 Jul 2010

SDI Pharmaceutical Company Image 2010 study: Novo Nordisk ranked top among endocrinologists

According to SDI's Pharmaceutical Company Image 2010 study, Novo Nordisk was ranked by endocrinologists as the top company overall. The company was mentioned by 62% of the endocrinologists who participated in the annual study - a substantial increase from last year, when it was mentioned by 52% of participants and ranked second.

7 Jul 2010

Investment report on Hemispherx BioPharma

MicroStockProfit.com announces an investment report featuring Hemispherx BioPharma Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

7 Jul 2010

Changes in Medicare Part B therapy rates likely to reduce Kindred Healthcare's revenues by $11M per year

Kindred Healthcare, Inc. today provided its estimate of the revenue effect of proposed rate changes to Medicare Part B therapy services included in the proposed Medicare Physician Fee Schedule rule. The proposed rule was released by the Centers for Medicare and Medicaid Services ("CMS") on June 25. The proposed rule is subject to a 60-day public comment period and is scheduled to become effective January 1, 2011.

7 Jul 2010

Modern Plastics adds MediPEEK-IM products

Modern Plastics has added extruded-plate MediPEEK-IM, a permanent implantable medical-grade PEEK (Polyetheretherketone), to its medical-grade plastics offering. MediPEEK-IM is a high-performance semi-crystalline thermoplastic designed for long-term body contact. The resin is produced to ASTM F2026 specifications and has been extensively tested to ISO-10993 requirements.

7 Jul 2010

ODA suggests tips for good oral hygiene to parents and kids

The Ontario Dental Association is asking parents to put oral health at the top of their kids camp preparation list. An oral care kit should be on the packing list, complete with a toothbrush, fluoride toothpaste and dental floss.

7 Jul 2010

Bilinguals more effective in certain executive functions: Study

The research group of Neuropsychology and Functional Neuroimaging at the Universitat Jaume I of Castellón, led by Professor of Basic Psychology, César ávila Rivera, has reported that bilinguals are faster and more efficient in certain tasks in which executive functions are used due to a different form of cerebral control.

7 Jul 2010

Cipher Pharmaceuticals reaches cumulative sales milestone for Lipofen

Cipher Pharmaceuticals Inc. today announced that it reached a cumulative sales milestone for Lipofen, the Company's fenofibrate product. Achieving this target triggers a US$1.0 million milestone payment from Kowa Pharmaceuticals America Inc., Cipher's U.S. marketing and distribution partner, which will be reflected in Cipher's revenue for the second quarter of fiscal 2010.

7 Jul 2010

Use of NSAIDs do not increase risk of heart attack in elderly patients: Study

Commonly used painkillers like ibuprofen do not increase the risk of heart attack in the elderly population, according to a new study. Researchers found that the use of these drugs - also called non-steroidal anti-inflammatory drugs - was also associated with a lower risk of death although they are not sure why.

7 Jul 2010